News
For many years, the most commonly used medicine to treat Type 2 diabetes has been metformin. It helps keep blood sugar levels ...
They were either given weekly exenatide injections or a placebo jab. At the end of the 96-week study those taking exenatide, ...
Now, researchers at Thomas Jefferson University have found that combining two other diabetes drugs—dapagliflozin and ...
Our study demonstrates reduction in postprandial glucose after exenatide injection in adolescents with type 1 diabetes. These effects were associated with delayed gastric emptying, and the results ...
n=8), weekly exenatide injections (Bydureon BCise®, n=8), or weekly 1 mg semaglutide injections (Wegovy®, n=8) for a 9-week treatment duration. Changes in weight will be measured. The study is ...
AstraZeneca Plc's (NASDAQ:AZN) Bydureon BCise (exenatide 2 mg prolonged-release suspension for injection) is indicated for type-2 diabetes. Novo Nordisk A/S' (NYSE:NVO) semaglutide is approved as ...
that require injection once a week or less are now available to prescribers in the form of Bydureon®(once-weekly exenatide). Several other formulations with unique structures and properties are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results